Physiological parameters for oral delivery and in vitro testing - Wikidata - wikimedia - TriplyDB

Physiological parameters for oral delivery and in vitro testing

Physiological parameters for oral delivery and in vitro testing

http://www.wikidata.org/entity/Q27687044

about

A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo data A Janus Mucoadhesive and Omniphobic Device for Gastrointestinal Retention Rapid Kinetics of Size and pH-Dependent Dissolution and Aggregation of Silver Nanoparticles in Simulated Gastric Fluid.Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling.Reevaluation and Classification of Duodenal Lesions in B6C3F1 Mice and F344 Rats from 4 Studies of Hexavalent Chromium in Drinking Water.A Mouse Intra-Intestinal Infusion Model and its Application to the Study of Nanoparticle Distribution.Assessment of gastrointestinal motor functions by MRI: a comprehensive review.Inorganic matrices: an answer to low drug solubility problem.New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.Drug release from matrix tablets: physiological parameters and the effect of food.In vitro-in vivo correlations: general concepts, methodologies and regulatory applications.Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.Current state and challenges in developing oral vaccines.Influence of multi-walled carbon nanotubes on the cognitive abilities of Wistar rats.Development and validation of a new dynamic computer-controlled model of the human stomach and small intestine.Gastrointestinal characterisation and drug solubility determination in animals.NanoClusters surface area allows nanoparticle dissolution with microparticle properties.Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.Development of a continuous dissolution/absorption system--a technical note.The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine.Correlating cellulose derivative intrinsic viscosity with mechanical susceptibility of swollen hydrophilic matrix tablets.The Development of Models Based on Linear and Nonlinear Multivariate Methods to Predict ADME/PK Properties Using Physicochemical Properties of Kinase, Protease Inhibitors, and GPCR Antagonists.Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs Clinicians' prescribing practices for bariatric surgery patients: is there an issue?Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry.Stability of plant virus-based nanocarriers in gastrointestinal fluids.Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models.Student Award for Outstanding Research Winner in the Undergraduate Category for the 2017 Society for Biomaterials Annual Meeting and Exposition, April 5-8, 2017, Minneapolis, Minnesota: Development and characterization of stimuli-responsive hydrogel Low colonic absorption drugs: risks and opportunities in the development of oral extended release products.Feasibility of capsule endoscopy for direct imaging of drug delivery systems in the fasted upper-gastrointestinal tract.Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.Pharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.Noninvasive vaccination against infectious diseases.A New Approach to Dissolution Testing by UV Imaging and Finite Element Simulations Multifunctional microspherical magnetic and pH responsive carriers for combination anticancer therapy engineered by droplet-based microfluidics

P2860

Q30578718-0FDEB50D-DEA5-4D2F-884E-1FAED5EDE8C2 Q30837039-BECC1233-732C-405A-A4B5-E54E32E44D51 Q30843529-D44214C8-947B-4036-BDB2-B4C5AC886093 Q33553580-B9B77185-33DC-4EE2-84F1-0B144ADB5DC4 Q35854694-84514983-40A4-4D2F-A378-97C681BED348 Q36019637-F3BD09F8-44F2-42AD-9B69-84247A11F632 Q36232481-C2989408-5C5F-45A1-B287-67C2508D12CD Q36672685-E9F9EE4D-19B0-4EEA-B116-A11E93D5F94C Q37448385-870E82D9-8F62-4DE6-917F-B747DFEA7C56 Q37833148-A500ED56-FE35-43E3-8091-F26780524475 Q38051672-0F91A480-C30F-4B8E-9083-084FE81FEC90 Q38110619-4F68A1C6-177C-4C82-A465-A18E08C35955 Q38223664-41F5B1FA-D671-4257-8BA2-7BA9B8F411C8 Q38541574-03CFBA65-DB63-4714-8207-1BCF42FF399A Q38922030-1B7E5FA8-2377-49A3-9D37-276B31B34EC3 Q39259629-CA38C7CF-98EE-48F7-BD78-89B6E24E3D7C Q39429064-A82EB068-22C3-4757-8ECD-44DD6E017795 Q40263997-8038F783-7D3D-4812-B9FB-661867363115 Q41622617-45E46B66-49D0-4D58-9B1A-2945071DDC55 Q41810733-304A48BB-BA3F-4102-BBE5-7282D3F95CA4 Q41823826-09F857FE-642C-4DEE-B3D7-6292B611025B Q41854431-4F4B33F2-3C2F-44C6-A9DE-7F296BB5FE96 Q41948835-B3B4B5EC-C65E-4381-9230-FF54C058870F Q41986927-8EA0E624-CECD-4995-9B4B-749FB8DD2727 Q42024380-F88CD729-A48B-4F58-92B9-32C8FF792516 Q42102051-3277D8E5-2AB8-45EA-AD28-F7B26113A9D7 Q42321064-662CAE31-DA8A-4F72-A686-22B76E80B858 Q45343457-51E86000-A758-4E5E-9FF0-23DAC6D25086 Q46820676-C9DBA0B5-81EA-4E05-A402-D5C72680E998 Q47258248-18C53493-5342-4FE5-AB83-8C8621DC9F65 Q47338381-B9F8295F-1056-40E9-A4AC-7569D9CBDD21 Q47577583-EBB8ED08-8C9E-4335-9446-65F3EA97EFB0 Q49500092-0BF91A55-6080-4809-9B93-5EE0283A53F7 Q51326782-E141FF1A-AE37-4C7D-B25A-C322EC3D4FBD Q51372033-808575B5-C415-4F6E-9957-EFE4ED90A1E1 Q52362750-AAC82CF7-BC08-44BB-89C1-ACB9B64A960D Q52602778-A633A816-F9B2-4890-8DE6-1C40363C79E9 Q58199053-957BE2CD-11A0-44DB-A928-9E0F0F40AD8D Q59189913-A2138E1A-EAE8-4E48-86B5-5E47463C83C2

P2860

Physiological parameters for oral delivery and in vitro testing

http://www.wikidata.org/entity/Q27687044

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Physiological parameters for oral delivery and in vitro testing

@ast

Physiological parameters for oral delivery and in vitro testing

@en

Physiological parameters for oral delivery and in vitro testing.

@nl

type

label

Physiological parameters for oral delivery and in vitro testing

@ast

Physiological parameters for oral delivery and in vitro testing

@en

Physiological parameters for oral delivery and in vitro testing.

@nl

prefLabel

Physiological parameters for oral delivery and in vitro testing

@ast

Physiological parameters for oral delivery and in vitro testing

@en

Physiological parameters for oral delivery and in vitro testing.

@nl

P1433

Q27687044-1D3D6786-172E-4233-81F2-AEE529633AA3

P1476

Q27687044-D209BDB8-09A9-4584-B9D0-7061C66A6712

P2093

Q27687044-129DC895-7ADD-43CB-8862-87704A5514BF

Q27687044-4CB0E869-3F2D-4A13-A35A-17DB648214A1

Q27687044-DACE0034-BD0E-456A-B0DC-1FCBA5167FEB

P2860

Q27687044-00B9CB56-F80B-4F26-8BDC-83A690ED9BB4

Q27687044-03436181-9ABE-4C09-9D67-3164FFDD6F41

Q27687044-05F48B0B-B907-49DC-989C-E42B201A2160

Q27687044-0D71538D-4F34-491B-A0FC-256F110562D2

Q27687044-0E039EA7-0883-43FA-8340-E64B949D1FEA

Q27687044-1179F6EE-25E9-4882-B78F-EE24B6FC13C9

Q27687044-182A81CB-CDE4-4877-B473-6CF4939B63AB

Q27687044-1AB63834-6955-4BA4-A978-A8F1B9F660D3

Q27687044-2021EB01-6AA6-41E2-880F-335DAE4D6247

Q27687044-251E4872-26EB-4F1D-A8E1-66668682797B

P304

Q27687044-76C1FE48-FF93-4E25-9BCC-8BC49048BD20

P31

Q27687044-DDC1A6EB-1DE5-4BCC-BAF2-1ADA48AF0D0E

P3181

Q27687044-3A8A7053-831C-4BEA-BC5B-C3BDD8AEC045

P356

Q27687044-37376939-13D4-455F-98D9-275B40971A58

P407

Q27687044-54EF09DF-C69C-436D-BD21-1A2A7F750C63

P433

Q27687044-575D0C37-6485-479A-93FA-318FFCBB7D59

P478

Q27687044-AAA518B2-EC7F-466F-8006-72E8D5A919F3

P577

Q27687044-A875302A-E388-4646-8CBD-1F4AD156F675

P5875

Q27687044-6645B03A-3D77-4CB5-A9F6-0CA3C2D315FA

P698

Q27687044-4EFCB713-9765-454F-B922-74183200CA13

P932

Q27687044-03DE6F84-E94E-4521-8A76-0E4E36BEA059

P3181

P356

P1433

Molecular Pharmaceutics

P1476

Physiological parameters for oral delivery and in vitro testing

@en

P2093

Deanna M. Mudie

http://www.w3.org/2001/XMLSchema#string

Gordon L. Amidon

http://www.w3.org/2001/XMLSchema#string

Gregory E. Amidon

http://www.w3.org/2001/XMLSchema#string

P2860

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Gastric response to increased meal viscosity assessed by echo-planar magnetic resonance imaging in humans.

Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging.

Effects of posture on the physiology of gastric emptying: a magnetic resonance imaging study.

Engineering tools for understanding the hydrodynamics of dissolution tests.

Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: a randomised double-blind, crossover study.

Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome.

Studies of intestinal digestion and absorption in the human.

Understanding gastric forces calculated from high-resolution pill tracking

Human duodenal mucosal brush border Na(+)/H(+) exchangers NHE2 and NHE3 alter net bicarbonate movement.

P304

1388-405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4675153

http://www.w3.org/2001/XMLSchema#string

P356

10.1021/MP100149J

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46168885

http://www.w3.org/2001/XMLSchema#string

P698

20822152

http://www.w3.org/2001/XMLSchema#string

P932

3025274

http://www.w3.org/2001/XMLSchema#string